Direct Oral Anticoagulants in Patients With Cancer and Nonvalvular Atrial Fibrillation

被引:6
作者
Davis, Margot K. [1 ]
Lim, Howard [1 ,2 ]
Lee, Agnes Y. Y. [1 ,2 ]
机构
[1] Univ British Columbia, Dept Med, Vancouver, BC, Canada
[2] BC Canc, Vancouver, BC, Canada
关键词
atrial fibrillation; direct oral anticoagulants; stroke; anticoagulants; WARFARIN; SAFETY; EFFICACY;
D O I
10.1016/j.jaccao.2021.07.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:425 / 427
页数:3
相关论文
共 12 条
[1]   Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients With Active Cancer [J].
Deitelzweig, Steven ;
V. Keshishian, Allison ;
Zhang, Yan ;
Kang, Amiee ;
Dhamane, Amol D. ;
Luo, Xuemei ;
Klem, Christian ;
Ferri, Mauricio ;
Jiang, Jenny ;
Yuce, Huseyin ;
Lip, Gregory Y. H. .
JACC: CARDIOONCOLOGY, 2021, 3 (03) :411-424
[2]   Patterns of Anticoagulation Use in Patients With Cancer With Atrial Fibrillation and/or Atrial Flutter [J].
Fradley, Michael G. ;
Ellenberg, Kerry ;
Alomar, Mohammed ;
Swanson, Justin ;
Kharod, Anant ;
Nguyen, Anh Thy H. ;
Khodor, Sara ;
Mishra, Shreya ;
Duong, Linh M. ;
Shah, Nirav ;
Armanious, Merna ;
Rhea, Isaac B. ;
Schabath, Matthew B. ;
Kip, Kevin E. .
JACC: CARDIOONCOLOGY, 2020, 2 (05) :747-754
[3]   Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs [J].
Haslam, Alyson ;
Prasad, Vinay .
JAMA NETWORK OPEN, 2019, 2 (05)
[4]   Effect of Non-vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients with Newly Diagnosed Cancer [J].
Kim, Kyu ;
Lee, Yong-Joon ;
Kim, Tae-Hoon ;
Uhm, Jae-Sun ;
Pak, Hui-Nam ;
Lee, Moon-Hyoung ;
Joung, Boyoung .
KOREAN CIRCULATION JOURNAL, 2018, 48 (05) :406-417
[5]   Rivaroxaban for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation and Active Cancer [J].
Laube, Eva S. ;
Yu, Anthony ;
Gupta, Dipti ;
Miao, Yimei ;
Samedy, Patrick ;
Wills, Jonathan ;
Harnicar, Stephen ;
Soff, Gerald A. ;
Mantha, Simon .
AMERICAN JOURNAL OF CARDIOLOGY, 2017, 120 (02) :213-217
[6]   Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients The ARISTOPHANES Study [J].
Lip, Gregory Y. H. ;
Keshishian, Allison ;
Li, Xiaoyan ;
Hamilton, Melissa ;
Masseria, Cristina ;
Gupta, Kiran ;
Luo, Xuemei ;
Mardekian, Jack ;
Friend, Keith ;
Nadkarni, Anagha ;
Pan, Xianying ;
Baser, Onur ;
Deitelzweig, Steven .
STROKE, 2018, 49 (12) :2933-2944
[7]   Efficacy and Safety of Apixaban Versus Warfarin in Patients with Atrial Fibrillation and a History of Cancer: Insights from the ARISTOTLE Trial [J].
Melloni, Chiara ;
Dunning, Allison ;
Granger, Christopher B. ;
Thomas, Laine ;
Khouri, Michel G. ;
Garcia, David A. ;
Hylek, Elaine M. ;
Hanna, Michael ;
Wallentin, Lars ;
Gersh, Bernard J. ;
Douglas, Pamela S. ;
Alexander, John H. ;
Lopes, Renato D. .
AMERICAN JOURNAL OF MEDICINE, 2017, 130 (12) :1440-+
[8]   Thromboembolic and bleeding complications during oral anticoagulation therapy in cancer patients with atrial fibrillation: a Danish nationwide population-based cohort study [J].
Ording, Anne G. ;
Horvath-Puho, Erzsebet ;
Adelborg, Kasper ;
Pedersen, Lars ;
Prandoni, Paolo ;
Sorensen, Henrik T. .
CANCER MEDICINE, 2017, 6 (06) :1165-1172
[9]   Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials [J].
Ruff, Christian T. ;
Giugliano, Robert P. ;
Braunwald, Eugene ;
Hoffman, Elaine B. ;
Deenadayalu, Naveen ;
Ezekowitz, Michael D. ;
Camm, A. John ;
Weitz, Jeffrey I. ;
Lewis, Basil S. ;
Parkhomenko, Alexander ;
Yamashita, Takeshi ;
Antman, Elliott M. .
LANCET, 2014, 383 (9921) :955-962
[10]  
Sebuhyan M, 2020, J MED VASC, V45, p6S31